• Subscribe
  • About us
  • Advertise with us

NeuroSens

Menu

Skip to content
  • Home
  • Neurology
  • Psychiatry

Topic: COVID-19

Effectiveness of COVID boosters in MS: an update

November 30, 2022  

ECTRIMS 2022 HIGHLIGHTS – SATURDAY, OCTOBER 29 EDITION

October 29, 2022  

ECTRIMS 2022 HIGHLIGHTS – THURSDAY, OCTOBER 27 EDITION

October 27, 2022  

Bivalent COVID booster approved in Canada

September 16, 2022  

COVID-19 and MS – updated findings

July 28, 2022  

COVID update: the 7th wave

July 13, 2022  

Key changes in Canadian MS care during the pandemic

July 7, 2022  

Pandemic prescribing – what changed?

July 6, 2022  

EAN 2022 HIGHLIGHTS – THURSDAY, JUNE 30 EDITION

June 30, 2022  

EAN 2022 HIGHLIGHTS – TUESDAY, JUNE 28 EDITION

June 28, 2022  
1
2
3
Next

Browse by Topic

  • EPILEPSY (36)
  • MS (412)
  • CLINICAL CASES IN MS (15)
  • BIOMARKERS IN MS (54)
  • AAN 2025 (5)
  • ACTRIMS 2025 (6)
  • Library (17)
  • AES 2024 (1)
  • ECTRIMS 2024 (6)
  • EAN 2024 (3)
  • AD (85)
  • AAN 2024 (5)
  • ACTRIMS Forum 2024 (2)
  • PD (77)
  • COVID-19 (58)
  • MIGRAINE (25)
  • DEPRESSION (36)
  • STROKE (22)
  • SCHIZOPHRENIA (25)
  • DEMENTIA (10)
  • SLEEP (2)
  • PAIN (3)
  • BPD (4)
  • ALS (1)

Popular Posts

  • CLINICAL CASES IN MS: A 24 Y.O. WOMAN WITH PARESTHESIAE AND NON-ENHANCING LESIONS posted on April 25, 2025
  • Proton pump inhibitors linked to neurological conditions posted on November 29, 2019
  • Ofatumumab – new data on efficacy and safety posted on April 14, 2025
Copyright 2025 Lind Publishing Inc All rights reserved. Developed by Integration New Media, INC. (INM)
Contact Us Terms and Conditions